KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Change in Inventory: 2014-2024

Historic Change in Inventory for Travere Therapeutics (TVTX) over the last 11 years, with Dec 2024 value amounting to $3.8 million.

  • Travere Therapeutics' Change in Inventory fell 178.86% to -$194,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.6 million, marking a year-over-year decrease of 113.73%. This contributed to the annual value of $3.8 million for FY2024, which is 90.43% down from last year.
  • Per Travere Therapeutics' latest filing, its Change in Inventory stood at $3.8 million for FY2024, which was down 90.43% from $39.4 million recorded in FY2023.
  • In the past 5 years, Travere Therapeutics' Change in Inventory ranged from a high of $39.4 million in FY2023 and a low of -$117,000 during FY2021.
  • Moreover, its 3-year median value for Change in Inventory was $3.8 million (2024), whereas its average is $14.8 million.
  • Per our database at Business Quant, Travere Therapeutics' Change in Inventory crashed by 102.31% in 2021 and then skyrocketed by 3,160.55% in 2023.
  • Travere Therapeutics' Change in Inventory (Yearly) stood at $5.1 million in 2020, then tumbled by 102.31% to -$117,000 in 2021, then skyrocketed by 1,133.33% to $1.2 million in 2022, then surged by 3,160.55% to $39.4 million in 2023, then plummeted by 90.43% to $3.8 million in 2024.